Cathie Wood Was Buying These 5 Stocks for 2024

Page 5 of 5

1. Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)

Cathie Wood’s Stake: $203,652,265

ARK Invest upped its stake in Utah-based clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) by 201% during the fourth quarter of 2023, ending the period with a $204 million stake in Recursion Pharmaceuticals Inc. (NASDAQ:RXRX). In July 2023 Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) had disclosed a $50 million investment from Nvidia for AI-based drug discovery.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the Cathie Wood’s Latest Stock Picks: 11 Biggest Positions and These Cathie Wood Stocks Are On Sale Now.

Page 5 of 5